• 01 NOV 2021

    November Is Pancreatic Cancer Awareness Month

    In honor of National Pancreatic Cancer Awareness Month (November) and the World Pancreatic Cancer Day (November 18th), we’ve compiled important statistics about this disease and how we plan to treat it. Pancreatic cancer is one of the deadliest forms of cancer.  It is the third leading cause of cancer-related deaths in the western world and

    Read more →
    • 23 SEP 2021

    Cell-Based Pro-Drug Strategy for Pancreatic Cancer

    PharmaCyte Biotech, which specializes in cell-based treatments for cancer and diabetes has announced that its clinical trial product, CypCaps™, remains stable and active after 18 months when stored at -80°C. The next timepoint milestone for the product comes at 24 months. CypCaps are genetically engineered human cells, specifically engineered to treat unresectable pancreatic cancer, and

    Read more →
    • 23 JUL 2019

    PharmaCyte’s Cell-in-a-Box encapsulation technology targeting cancer, diabetes

    By  BIOTUESDAYS PharmaCyte Biotech (OTCQB:PMCB) is developing cellular therapies for its lead pancreatic cancer program and for diabetes that are based on a proprietary cellulose-based live cell encapsulation technology known as a Cell-in-a-Box. “When used for pancreatic cancer treatment, the combination of Cell-in-a-Box encapsulation plus a cancer prodrug, which needs to be converted to its

    Read more →
    • 09 APR 2018

    Encapsulation Enters the Pharma Industry Mainstream

    Analysis | By Brian Salmons and Walter H. Gunzburg The therapy is based on induced pluripotent stem cells that are engineered to become insulin-producing beta cells The recently announced licencing deal between Eli Lilly and Sigilon to develop an allogeneic, off-the-shelf, cell therapy to treat type 1 diabetes has finally demonstrated acceptance by the mainstream

    Read more →
    • 12 DEC 2017

    Managing Diabetes During the Holidays

    For many, holidays are a time of joy and celebration, but for diabetics, they could also be filled with stress and diabetes-related problems. A 2014 study published in Diabetes Care revealed that in the month after Christmas, diabetics’ HbA1c, average blood glucose level, cholesterol level, and weight increases. Part of this is due to

    Read more →
    • 04 APR 2017

    Celluar Microencapsulation – Cell Encapsulation for Drug Delivery & Disease Treatment

    INTRODUCTION Regenerative medicine is not all that new; tissue and organ transplants have been around for decades. However, the Mayo Clinic has said, “But advances in developmental and cell biology, immunology, and other fields have unlocked new opportunities to refine existing regenerative therapies and develop novel ones.” It has also stated, “Regenerative medicine is a

    Read more →
    • 13 JUN 2016

    Promising Diabetes Treatment Using Human Liver Cells May Be on the Horizon

    Diabetes News Journal Article By Katie McCallum A collaboration between Prof. Ann Simpson of the University of Technology Sydney (UTS) in Australia and a U.S. clinical stage biotechnology company, PharmaCyte Biotech, shows promise for a unique alternative therapy for a generation of type 1 diabetes patients. Utilizing human liver cells engineered to supply the

    Read more →
    • 05 OCT 2015

    Imaging to Cure Cancer: Valuable Contribution of Radiology for Clinical Trial Success

    Written by Ι Dr. Ron Korn, Founder, Chairman and Chief Medical Officer at Imaging Endpoints “I keep dreaming of a future, a future with a long and healthy life, not lived in the shadow of cancer but in the light” – Patrick Swayze Introduction Pancreatic cancer is one of the most lethal malignancies. It is often

    Read more →
    • 02 SEP 2015

    Oncology KOLS: An Important Piece of the Puzzle

    PharmaVOICE Magazine September 2015 Edition NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable. The oncology market is changing. Scientific advances are transforming cancer treatments, with outcomes for patients improving. At the same time, patients are challenged by access concerns

    Read more →
    • 05 AUG 2015

    PharmaCyte Seeks to Solve Pancreas Puzzle with Cell-in-a-Box®

    BioWorld Article by Marie Powers News Editor Considering its relatively inconspicuous presence in the body, the pancreas can wreak havoc on human health through two major diseases: diabetes and pancreatic cancer. Both can be deadly – the former from the condition itself or from long-term complications and the latter from advanced disease that may be

    Read more →